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Abstract
Background: Hemolytic specimens are among the most 
challenging preanalytical issues in laboratory diagnos-
tics. The type of blood collection tube in use is claimed 
to influence in vitro hemolysis. We aimed to examine this 
hypothesis and estimate the respective financial impact, 
evaluating routine blood samples from the past 4 years.
Methods: A total of 47,820 hemolysis index (HI) values 
from five different time intervals (IV1–IV5) were compared 
against each other, representing the following tubes: IV1-
Sarstedt Monovette; IV2-8 mL/16 × 100 mm Greiner BioOne 
(GBO) Vacuette; IV3/IV4-5 mL/16 × 100 mm GBO Vacuette; 
IV5-4.5  mL/13 × 75  mm GBO Vacuette. For estimation of 
the economic impact, material, personnel and analytical 
costs were calculated.
Results: HI mean values in time interval IV2 were sig-
nificantly higher than in all other intervals, while mean 
values amongst all other intervals were comparable. The 
number of moderately and severely hemolyzed samples 
increased with incrementing vacuum. Overall comparable 
costs between intervals IV1 and IV5 were €11,370, €14,045, 
€12,710, €11,213 and €8138 per 10,000 samples, respectively.
Conclusions: Aspiration tubes and low vacuum tubes 
show comparable hemolysis rates. Increasing vacuum 
levels are associated with higher hemolysis rates. By 
decreasing in vitro hemolysis, financial savings up to 
€5907 per 10,000 samples could be gained.
Keywords: blood collection; hemolysis; preanalytic.
Zusammenfassung
Einleitung: Hämolytische Proben stellen eine der größten 
präanalytischen Herausforderungen eines jeden medizi-
nischen Labors dar. Als einer der möglichen ursächlichen 
Faktoren wird das in Verwendung befindliche Blutabnah-
mesystem angesehen. Unser Ziel war es, diese Hypothese 
sowie die entsprechenden Folgekosten anhand von Routi-
neproben der letzten 4 Jahre zu überprüfen.
Methoden: 47,820 Hämolyseindices (HI) aus fünf Zeitin-
tervallen (IV1–IV5), in welchen die folgenden Lithium-
Heparin Blutabnahmeröhrchen in Verwendung waren, 
wurden miteinander verglichen: IV1-Sarstedt Monovette; 
IV2-8 mL/16 × 100 mm Greiner BioOne (GBO) Vacuette; IV3/
IV4-5 mL/16 × 100 mm GBO Vacuette; IV5-4,5 mL/13 × 75 mm 
GBO Vacuette. Zur Abschätzung der Folgekosten wurden 
Material-, Personal- und Analysekosten berechnet.
Ergebnisse: Die HI Mittelwerte aus Intervall IV2 
waren signifikant höher als jene aller anderen Zeit-
intervalle. Die Mittelwerte aus den Intervallen IV1, 
IV3, IV4 und IV5 unterschieden sich nicht statis-
tisch voneinander. Die Anzahl mittelgradig und 
stark hämolysierter Proben stieg mit zunehmendem 
Vakuum. Die Folgekosten hämolysierter Proben in den 
Intervallen IV1–IV5 betrugen €11,370, €14,045, €12,710, 
€11,213 und €8138, jeweils auf 10,000 Proben berechnet.
Schlussfolgerungen: Während Aspirations- und Niedrig-
Vakuum-Röhrchen vergleichbare Hämolyseraten zeigen, 
steigen diese mit zunehmendem Vakuum an. Durch eine 
Senkung der Hämolyseraten konnte eine Ersparnis von 
bis zu €5907 pro 10,000 Proben erzielt werden.
Schlüsselwörter: Blutabnahme; Hämolys; Präanalytik
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Introduction
Laboratory analyses of the highest quality are crucial for 
accurate diagnosis and treatment as well as for prognostic 
evaluation of patients. It was estimated that 70%–80% of 
all healthcare decisions, that influence clinical decision 
making, involve one or more laboratory investigations 
[1]. Hence, errors within the total laboratory process may 
lead to harmful consequences for the patient due to inap-
propriate further investigations and treatment as well 
as financial consequences due to recollection of speci-
men and re-analyses. When reviewing the types and fre-
quencies of laboratory errors, the vast majority (61.9%) 
is found to occur in the preanalytical phase [2]. Within 
these types of errors hemolytic blood specimen are the 
foremost cause of sample rejection, which, according to 
a survey of 453 laboratories, occurs five times more fre-
quently than the second most cited reason, insufficient 
specimen quantity to perform the test [3]. Circumstances 
leading to in-vitro hemolysis are various and can be found 
in different process steps of specimen handling, includ-
ing phlebotomy, transport, intra-laboratory processing or 
storage [4]. One of these variables is the type of blood col-
lection system in use [5–8]. Vacuum systems are known to 
increase the rate of hemolytic specimen compared to aspi-
ration systems due to higher shear stress, subsequently 
leading to damage of red blood cells [7, 9]. This might be 
avoided by the use of low vacuum tubes, although the lit-
erature to this topic is conflicting [10–12].
In our hospital compound setting, consisting of three 
different sites, blood collection systems in use varied 
between vacuum and aspiration systems and were there-
fore standardized in 2011. In the following years different 
sizes and volumes of vacuum-based lithium-heparin (LH) 
tubes were introduced with the exception of the pediatric 
department, which continued to use an aspiration system. 
Based on this setting, we aimed to compare hemolysis 
rates in aspiration vs. vacuum blood collection systems 
as well as in low vs. high vacuum tubes, retrospectively. 
Additionally, we estimated the financial impact of hemo-
lytic blood specimen in this real life clinical setting as 
follow-up to our previous hypothetical study on the costs 
of hemolysis [13].
Materials and methods
The Landeskrankenhaus (LKH) Salzburg as part of the university 
hospital of Salzburg, in which our study was performed, holds 
1143 beds with approximately 77,000 inpatient visits and 561,000 
outpatient visits per year. Except for the neurology, neurosurgery, 
 psychiatry and geriatrics departments, which are located in a second 
site [Christian Doppler Klinik (CDK) Salzburg], all common medical 
specialties of a hospital center are provided. These two clinics, LKH 
and CDK, together with a third site, an outpost about 70 km away 
from the central sites, form the Salzburger Landeskliniken (SALK). 
Since the blood collection systems in use differed between these clin-
ics, a harmonization process was started in 2010. After a public ten-
dering procedure, the Vacuette™ system from Greiner BioOne (GBO, 
 Kremsmünster, Austria) was established in all of the SALK sites. The 
LKH was using the Monovette™ system from Sarstedt (Nümbre-
cht, Germany) which was switched on the 17th of March 2011 in all 
the departments with the exception of the departments of pediat-
rics, pediatric surgery and neonatology, which continued using the 
Sarstedt aspiration system. In preparation for these changes all phy-
sicians and nurses were trained in blood collection using the new 
system, as well as in preanalytics.
Immediately after the system switch we observed a signifi-
cant rise of hemolysis rates in the 8  mL lithium-heparin (LH) gel 
blood collection tubes (16 × 100 mm, 8 mL, mm REF: 455083, GBO, 
 Kremsmünster, Austria) and therefore decided to switch to a 5  mL 
low vacuum tube (16 × 100 mm, 5 mL, REF: 455012, GBO). The replace-
ment of tubes was performed on the 12th of April 2011. In November 
2013 we switched to a 4.5 mL LH tube without gel due to technical 
issues. During this time, however, the tubes outer dimensions also 
changed (13 × 75 mm, 4.5 mL, REF: 454049, GBO).
After approval by the Institutional Ethics Committee, we ana-
lyzed hemolysis index (HI) values at different time intervals (IV) and 
compared them accordingly. An overview of the time intervals and 
the respective system in use is shown in Table 1. During interval one 
(IV1) the Sarstedt system was in use, whereas in interval two (IV2) 
high vacuum/high volume (8 mL) LH-tubes with a 16 × 100 mm outer 
dimension were introduced. In interval three (IV3) and four (IV4) 
blood collection was performed using the 5 mL/16 × 100  mm low 
vacuum tubes. Data from IV4 were collected to test for changes in 
hemolysis rates due to declining awareness of the preanalytics train-
ing which was performed in spring 2011. Hemolysis data from the 
fifth interval (IV5) represent the usage of high vacuum/low volume 
Table 1: Description of the different blood collection systems in use over the five time intervals (IV1–IV5).
  Time period  Vendor   Outer dimensions, mm  Vacuum  Volume, mL  n
IV1   01.01.2011–01.03.2011  Sarstedt  15 × 75  None   4.7   9836
IV2   18.03.2011–12.04.2011  GBO   16 × 100  High   High (8)   4418
IV3   13.04.2011–13.06.2011  GBO   16 × 100  Low   Low (5)   10,793
IV4   01.01.2012–01.03.2012  GBO   16 × 100  Low   Low (5)   11,508
IV5   01.01.2014–01.03.2014  GBO   13 × 75  High   Low (4.5)   11,265
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tubes (4.5 mL/13 × 75 mm) without gel. According to Boyle’s law, the 
calculated vacuum within the tubes used in IV2, IV3/4 and IV5 was 
11.5 psi, 7.2 psi and 11.0 psi, respectively [14]. To see if there were ini-
tial difficulties in using the new collection system, we additionally 
evaluated mean day to day HI values and the number of hemolyzed 
specimens within IV2.
As already mentioned the departments treating pediatric 
patients continued using the Sarstedt system and were therefore 
excluded from the calculations. We also excluded our emergency 
department due to the fact that on this ward blood usually is drawn 
through IV catheters, which may result in severely higher hemolysis 
rates [15].
Hemolysis index (HI) was measured using the COBAS analyzers 
(Roche, Basel, Switzerland), with a HI of one being equal to a concen-
tration of 1 mg/dL of free hemoglobin [16, 17]. To define hemolysis we 
referred to the official documents and packaging inserts of the manu-
facturer, which state, that the first laboratory parameter affected 
by hemolysis is altered at an HI level of  ≥ 10. Two additional cutoffs 
were set at 50 and 100, to define moderately and severely hemolyzed 
 samples, respectively.
Calculation of costs
The economic impact of hemolysis during the different intervals was 
calculated based upon our previous work, grading hemolysis into 16 
HI groups [13]. We evaluated the percentage of samples in the dif-
ferent intervals with HI values within the range of the respective HI 
group. In these samples, we analyzed the number of ordered param-
eters which are affected by the respective grade of hemolysis, accord-
ing to official documents and packaging inserts of the manufacturer. 
Subsequently, we multiplied personnel, material and laboratory 
costs with the actual number of hemolyzed samples and affected 
parameters. Analytical costs were calculated using a common scale 
of charges for medical laboratory analyses in Germany, which, 
amongst other available scales, most closely reflects the analytical 
costs [18]. For better comparison between the groups we factorized 
overall costs on 10,000 samples in each interval.
Statistical analysis
To estimate the sample sizes for each group, a power analysis was 
performed, based on an effect size of 0.1, an alpha error of 0.05 and 
a power of 0.95 using G-Power v3.1 [19]. This analysis yielded 2600 
samples for each group. However, since data for the different periods 
were easily obtainable we set this value as the minimum sample size.
One-way-ANOVAs were performed for comparison of mean val-
ues and the amount of hemolyzed samples between all time inter-
vals. Differences were considered significant at p-values  < 0.05.
Results
We collected 47,820 HI values within five different time 
periods (Table 1). When comparing HI mean values in the 
respective intervals against each other, values in IV2 were 
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Figure 1: Differences between mean hemolysis index (HI) values 
(A) and amount of hemolyzed samples (B) between time intervals 
IV1–IV5.
*p  ≤  0.05; **p  ≤  0.01; ***p  ≤  0.001; ****p  ≤  0.0001.
significantly higher than in all other intervals (p < 0.0001 
for all). Amongst groups IV1, IV3, IV4 and IV5, no signifi-
cant differences were found (p > 0.05). The percentage of 
samples with HI values greater than 10, 50 or 100 differed 
substantially between most of the time intervals (Figure 1). 
As expected, hemolysis rates within the pediatric depart-
ment remained unchanged (data not shown).
Mean day to day HI values as well as the amount of 
hemolyzed samples showed a slight downward trend 
within IV2. On the last day before the system switch the 
mean HI value was 12.2 and the percentage of samples 
with an HI value  ≥ 10,  ≥ 50 and  ≥ 100 was 36.8%, 4.0% and 
1.5%, respectively (Figure 2).
We calculated €0.145 material costs for two tubes, 
a tube holder and a 21G needle. Blood collection by the 
nursing staff takes 371  s on average, including 55  s for 
preparation and 316 s for collection and post-processing 
(evaluation from an internal project – data not shown). 
Based on the respective wages, personnel costs for one 
blood collection were €2.93 [20]. Analytical costs for the 
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time periods IV1, IV2, IV3, IV4 and IV5 were €832.35, 
€736.10, €941.50, €892.90 and €1006.10, respectively. 
Summing up material, personnel and analytical costs for 
each interval, the economic impact was €11,183 (samples 
n = 9836), €6205 (samples n = 4418), €13,718 (samples 
n = 10,793), €12,904 (samples n = 11,508) and €9168 
(samples n = 11,265), respectively. When factorizing each 
interval up to 10,000 samples, overall comparable costs 
between these intervals were €11,370, €14,045, €12,710, 
€11,213 and €8138, respectively (Table 2).
Discussion
Hemolytic blood specimens are one of the most challeng-
ing preanalytic issues in laboratory medicine. Not only 
because it is the most frequent preanalytical error, but 
also because it is difficult to directly influence hemoly-
sis levels by the laboratory staff [3]. To reduce hemolysis 
rates, the laboratory has to train phlebotomists in pre-
analytics and blood collection and motivate them to keep 
hemolysis levels low. Such motivators can be profession-
alism, i.e. trying to provide the best service possible to the 
patient, economic behavior, i.e. trying to reduce costs due 
to repeated blood collection/analyses or personal inter-
est, i.e. by trying to become an “Hemolysis Champion”, as 
McGarth et  al. describe it [21]. Additionally, there is one 
possibility for the laboratory to directly influence hemoly-
sis by controlling the blood collection system in use. In 
theory, higher shear stress in vacuum systems leads to 
more damaged red blood cells compared to gradually 
drawing the plunger of an aspiration system. However, 
studies comparing vacuum collection systems against 
aspiration systems on larger scales are rare and conflict-
ing. Lippi et  al. compared the Becton Dickinson (BD) 
Vacutainer™ system against the Sarstedt system, in both 
vacuum and aspiration mode, in 20 healthy volunteers 
and showed that blood collection by vacuum, regardless 
of the vendor, increases hemolysis rates [9]. In two subse-
quent retrospective studies, Lippi et al. as well as Goege-
buer et al. confirmed a reduction in hemolysis rates by the 
use of an aspiration system compared to a vacuum system 
[6–8]. Other investigators, focusing on blood collection 
through an IV-catheter, reported similar results [11, 22, 23]. 
However, a study by Seguin et al., prospectively analyzing 
samples from 1206 patients presenting at the emergency 
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Figure 2: Day-to-day mean values (A) and number of samples (%) 
with hemolysis index (HI) levels  ≥ 10,  ≥ 50 and  ≥ 100, respectively (B) 
within time interval 2.
Table 2: The financial impact of hemolysis in the five time periods.
   Costs 
 
Samples, n   Total costs for 10,000 samples, €
Material, €  Personnel, €  Analytical, €  Total, €
IV1  639  9712  832  11,183  9836  11,369
IV2  338  5132  736  6205  4418  14,045
IV3  789  11,988  942  13,718  10,793  12,710
IV4  741  11,269  893  12,904  11,508  11,213
IV5  504  7658  1006  9168  11,265  8138
For better comparison, costs were factorized to a total of 10,000 samples.
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department, did not find significant differences in hemol-
ysis rates comparing the BD Vacutainer system against 
syringe blood collection [24]. Also Dugan et  al., survey-
ing factors affecting hemolysis in 100 randomly chosen 
patients, reported no difference in blood collection per-
formed by syringe compared to vacuum [25].
When comparing different vacuum systems, the 
vendor as well as the tube volume in combination with the 
outer dimensions of the tube influenced hemolysis levels. 
Almagor et al. reported lower hemolysis levels when using 
BD vacuum tubes compared to those from GBO, a finding 
later confirmed by Goegebuer et al. [5, 6]. However, these 
results could be biased, since Goegebuer et al. compared 
GBO 8 mL Vacuette tubes against BD 4 mL and 6 mL Vacu-
tainer tubes. In the study of Almagor et al. the tube holder 
differed between the two groups. In the Vacuette group 
the GBO Holdex with an eccentric luer was used, which 
might additionally influence hemolysis rates [26].
A lower volume in blood collection tubes is accom-
panied by lower vacuum levels and subsequently lower 
shear stress with less erythrocyte damage. However, this 
only applies to tubes with comparable outer dimensions. 
Giavarina et al., Heiligers-Duckers et al., Heyer et al. and 
Cox et al. demonstrated the relationship between vacuum 
level and hemolysis rate in clinical practice [10, 11, 22, 27]. 
Contradictory to these studies, Lippi et al. found a signifi-
cant elevated hemolysis rates in lower volume tubes [12]. 
However, this study compared two types of vacuum tubes 
with different outer dimensions.
In our hospital, the aspiration blood collection system 
from Sarstedt was replaced by the Vacuette™ system from 
GBO in 2011. After switching from the Sarstedt system (IV1) 
to the high vacuum/high volume tubes (8 mL/16 × 100 mm) 
from GBO (IV2) mean HI values as well as the number of 
hemolyzed samples increased (Figure 1). This effect was 
most probably caused by higher shear stress due to the 
vacuum. However, initial difficulties in using the new 
system must be taken into account. Therefore, we evalu-
ated the mean day-to-day HI values and the number of 
hemolyzed specimens within the first time period after 
the system switch and found a slight decline in hemoly-
sis rates over the 26  days in which these high vacuum/
high volume tubes were in use (Figure 2). Hemolysis 
levels and the number of moderate to severely hemolyzed 
samples using the low vacuum tubes (IV3) dropped to 
values similar to those from the Sarstedt system (IV1). We 
also evaluated if the effect of the training in preanalytics 
and handling of the new system, which was performed 
prior to the first system switch, decreased over time. This 
would result in increasing hemolysis rates. After about 
1 year in which the new tubes were in use (IV4), we could 
observe a slight non-significant decline in hemolysis 
mean values and an increase in the amount of moderately 
hemolyzed samples compared to IV3 while the amount of 
slightly hemolyzed samples declined and those severely 
hemolyzed stayed almost the same (Figure 1). In conclu-
sion, a decreasing awareness of preanalytical issues might 
influence hemolysis.
After switching from the low vacuum tubes to high 
vacuum/low volume (4.5 mL/13 × 75 mm) tubes (IV5), 
hemolysis mean values increased only slightly and non-
significantly, however, the amount of moderately and 
severely hemolyzed samples increased significantly. Since 
the volume in these tubes (4.5 mL) stayed nearly the same 
compared to the previously used tube (5 mL) while the 
tube itself was downsized from 16 × 100 mm to 13 × 75 mm, 
the vacuum subsequently increases. This fact in combina-
tion with the observations of hemolysis during our previ-
ous system switches fits perfectly into the theory that the 
amount of vacuum is a major factor in producing hemoly-
sis as already hypotized by others [6–9, 11, 22, 23].
Therefore, changing the blood collection system 
from aspiration to vacuum does not increase hemolysis 
rates if phlebotomists, nurses or physicians are trained 
accordingly and if low vacuum tubes are used. However, if 
switching to a standard 13 × 75 mm tube (high vacuum/low 
volume) a significant increase in moderately and severely 
hemolyzed samples must be taken into account.
For calculations of the financial impact of hemolysis 
the number of hemolyzed samples is far more important 
than the HI mean value, since personnel costs are respon-
sible for the majority of costs (86%) followed by analytical 
(8.3%) and material costs (5.7%). Overall costs in the time 
periods IV1–IV5, adjusted to 10,000 samples were €11,370, 
€14,045, €12,710, €11,212 and €8138, respectively (Table 2). 
Since hemolytic samples are less frequent but more 
severely hemolyzed in IV5, the costs caused by hemolytic 
samples are the lowest in this interval. Subsequently the 
potential savings would be €5907 per 10,000 samples at 
most (IV2 vs. IV5), depending on the collection system in 
use. These real life numbers differ, compared to those in 
our previous hypothetical work [13]. As we already stated 
in this previous work, this is due to the fact that not every 
laboratory parameter, which is influenced by hemolysis is 
measured in every single sample the lab receives.
To define hemolysis we referred to the official docu-
ments and packaging inserts of the manufacturer, which 
state, that lactate dehydrogenase measurement is affected 
by hemolysis already at HI values  ≥ 10. The HI cut-off of 10 
fits nicely to that proposed by Lippi et al., who calculated 
a reference range for HI in 135 unselected outpatients 
according to CLSI document 28-A3 with an upper limit for 
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LH plasma of 0.13 g/L measured on the Cobas c50 [28]. 
These levels however are quite low and would cause a 
hemolysis frequency of about 30% (Figure 1). When defin-
ing a hemolysis cut-off at an HI value of 50, as proposed 
by many authors [6, 10, 26, 29], our findings would look 
somewhat different. The high vacuum/high volume tubes 
(IV2) would still be causing most hemolytic samples, 
however, there would be significantly more hemolyzed 
samples when using the high vacuum/low volume tubes 
(IV5) compared to the Sarstedt system (IV1) or the low 
vacuum tubes (IV3, IV4) (Figure 1). Also the subsequent 
costs would change, being €1027, €3505, €825, €1026, and 
€2003 per 10,000 samples in IV1, IV2, IV3, IV4 and IV5, 
respectively. These findings show that a harmonization 
of hemolysis measurements and HI cut-offs is urgently 
needed [16].
A potential limitation of our study is represented by 
the fact that IV2 only covers 26 days, since we changed 
the collection tube from 8 mL to 5 mL quickly, whereas 
the other time periods spread over 2 months each. Addi-
tionally, it should be mentioned, that we focused on 
frequently ordered analytes in clinical chemistry when 
calculating subsequent costs. Analytes from other labo-
ratory specialties, which are also influenced by hemoly-
sis, such as coagulation parameters, were not taken 
into account, since we had no HI cut-off levels for these 
parameters [30]. Also, as described in our previous work, 
the analytic costs used in our setting reflect the charge-
able prize, rather than the laboratory costs [31]. Finally, 
we only calculated primary costs of hemolysis. Secondary 
costs have to be considered, but are very hard to put in 
numbers. Such costs could be caused by prolonged time 
to diagnosis and subsequent delay of treatment onset 
with a respectively extended hospital stay or by further 
inappropriate investigations.
In conclusion, vacuum blood collection tubes were 
not associated with higher hemolysis rates compared to 
the aspiration system when tubes with low vacuum levels 
were used. The hemolysis rate was positively associated 
with the vacuum levels of the tubes, hence, the most 
severe hemolysis levels were observed using the high 
vacuum/high volume tube (8 mL/16 × 100 mm). However, 
we could not define to which extent these results were 
influenced by initial difficulties in handling the new col-
lection system. Reducing the hemolysis rate by using 
adequate collection systems could contribute to financial 
savings up to €5907 per 10,000 samples.
We urge each laboratory to use preanalytic quality indi-
cators to keep track of this essential concern and to compare 
its hemolysis levels with those from other laboratories since 
“You can’t improve what you don’t measure” [32].
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